Harmony Biosciences is a U.S. commercial-stage pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs. Established in 2017 by founder Paragon Biosciences LLC, our mission is to positively impact the lives of those living with rare diseases who are so often underserved.
$37.09 +0.21 (0.57%)
As of 02/24/2021 15:59:56 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.